Crossmark

Letter to the Editor: Comment on ‘‘Cytoreductive Surgery with or without HIPEC After Neoadjuvant Chemotherapy in Ovarian Cancer: A Phase 3 Clinical Trial’’

Crossref DOI link: https://doi.org/10.1245/s10434-022-11432-4

Published Online: 2022-02-15

Published Print: 2022-05

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Carneiro, Vandré Cabral Gomes

Ramalho, Nathalia Moreira
License Information

Text and Data Mining valid from 2022-02-15

Version of Record valid from 2022-02-15
More Information

Article History

Received: 1 December 2021

Accepted: 12 December 2021

First Online: 15 February 2022

Disclosure

: Vandré Cabral Gomes Carneiro and Nathalia Moreira Ramalho declare no conflicts of interest.

Document is current

Any future updates will be listed below